Skip to main content
Erschienen in: Virchows Archiv 5/2021

24.07.2021 | Original Article

Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis

verfasst von: Yukihiro Wada, Masayuki Iyoda, Taihei Suzuki, Shohei Tachibana, Nobuhiro Kanazawa, Kei Matsumoto, Hirokazu Honda

Erschienen in: Virchows Archiv | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Exostosin 1 and exostosin 2 (EXT1/EXT2) on glomerular basement membrane (GBM) were recently reported as novel putative antigens in secondary membranous nephropathy with autoimmune disease. However, the clinical significance of glomerular EXT1/EXT2 remains elusive in patients with lupus nephritis (LN). The immunofluorescence staining pattern of glomerular EXT1/EXT2 is also undetermined in membranous LN (MLN) or proliferative LN (PLN). We cross-sectionally analyzed patients with MLN (pure class V, n = 11) and PLN (class III, IV, and mixed class III/IV + V, n = 22) who underwent renal biopsies between 2010 and 2020 at Showa University Hospital. Glomerular EXT1/EXT2 expressions were evaluated by immunofluorescence. T-helper (Th) cell-related serum inflammatory cytokines were measured using enzyme-linked immunosorbent assay. The positivity for both EXT1/EXT2 was higher in patients with MLN than PLN (90.9% vs 63.6%, P = 0.212). MLN showed global and bright granular EXT1/EXT2 expressions along GBM, while PLN showed segmental and moderate expressions on GBM. Additionally, glomerular EXT1/EXT2 positivity was not associated with the degree of proteinuria or renal function in MLN and PLN patients, but the levels of serum anti-dsDNA antibody and circulating immune complexes were lower in patients with EXT1/EXT2-positive MLN than EXT1/EXT2-negative PLN. Moreover, serum complement levels and IL-4/IFN-γ ratios were elevated in EXT1/EXT2-positive MLN than EXT1/EXT2-negative PLN. Collectively, immunofluorescence staining for glomerular EXT1/EXT2 had characteristic patterns between MLN and PLN. Glomerular EXT1/EXT2 expressions tended to be high in Th2-dominant MLN patients without severe hypocomplementemia and elevated autoantibodies. Thus, EXT1/EXT2 might be involved in the unique developmental mechanism of MLN.
Literatur
1.
Zurück zum Zitat Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121CrossRef Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121CrossRef
2.
Zurück zum Zitat Parikh SV, Almaani S, Brodsky S, Rovin BH (2020) Update on lupus nephritis: core curriculum. Am J Kidney Dis 76:265–281CrossRef Parikh SV, Almaani S, Brodsky S, Rovin BH (2020) Update on lupus nephritis: core curriculum. Am J Kidney Dis 76:265–281CrossRef
3.
Zurück zum Zitat Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13:483–495CrossRef Yu F, Haas M, Glassock R, Zhao MH (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 13:483–495CrossRef
4.
Zurück zum Zitat Ward F, Bargman JM (2016) Membranous lupus nephritis: the same, but different. Am J Kidney Dis 68:954–966CrossRef Ward F, Bargman JM (2016) Membranous lupus nephritis: the same, but different. Am J Kidney Dis 68:954–966CrossRef
5.
Zurück zum Zitat Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D’Agati VD et al (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789–796CrossRef Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D’Agati VD et al (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789–796CrossRef
6.
Zurück zum Zitat Miyake K, Akahoshi M, Nakashima H (2011) The subset balance in lupus nephritis. J Biomed Biotechnol 2011:980286CrossRef Miyake K, Akahoshi M, Nakashima H (2011) The subset balance in lupus nephritis. J Biomed Biotechnol 2011:980286CrossRef
7.
Zurück zum Zitat Miyake K, Adachi K, Watanabe M, Sasatomi Y, Ogahara S, Abe Y, Ito K et al (2014) Parasites alter the pathological phenotype of lupus nephritis. Autoimmunity 47:538–547CrossRef Miyake K, Adachi K, Watanabe M, Sasatomi Y, Ogahara S, Abe Y, Ito K et al (2014) Parasites alter the pathological phenotype of lupus nephritis. Autoimmunity 47:538–547CrossRef
8.
Zurück zum Zitat Selvaraja M, Abdullah M, Arip M, Chin VK, Shah A, Amin Nordin S (2019) Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis. PLoS One 14:e0224707CrossRef Selvaraja M, Abdullah M, Arip M, Chin VK, Shah A, Amin Nordin S (2019) Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis. PLoS One 14:e0224707CrossRef
9.
Zurück zum Zitat Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4:542–548CrossRef Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4:542–548CrossRef
10.
Zurück zum Zitat Sigdel KR, Duan L, Wang Y, Hu W, Wang N, Sun Q, Liu Q et al (2016) Serum cytokines Th1, Th2, and Th17 expression profiling in active lupus nephritis-IV: from a Southern Chinese Han population. Mediators Inflamm 2016:4927530CrossRef Sigdel KR, Duan L, Wang Y, Hu W, Wang N, Sun Q, Liu Q et al (2016) Serum cytokines Th1, Th2, and Th17 expression profiling in active lupus nephritis-IV: from a Southern Chinese Han population. Mediators Inflamm 2016:4927530CrossRef
11.
Zurück zum Zitat Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM et al (2019) Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30:1123–1136CrossRef Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM et al (2019) Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30:1123–1136CrossRef
12.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRef
13.
Zurück zum Zitat Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRef Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686CrossRef
14.
Zurück zum Zitat Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRef Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRef
15.
Zurück zum Zitat Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M et al (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558CrossRef Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M et al (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558CrossRef
16.
Zurück zum Zitat Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T (2002) Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41:936–942CrossRef Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T (2002) Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41:936–942CrossRef
17.
Zurück zum Zitat Hihara K, Iyoda M, Tachibana S, Iseri K, Saito T, Yamamoto Y, Suzuki T et al (2016) Anti-Phospholipase A2 Receptor (PLA2R) Antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy. PLoS One 11:e0158154CrossRef Hihara K, Iyoda M, Tachibana S, Iseri K, Saito T, Yamamoto Y, Suzuki T et al (2016) Anti-Phospholipase A2 Receptor (PLA2R) Antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy. PLoS One 11:e0158154CrossRef
18.
Zurück zum Zitat Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K et al (2018) Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS One 13:e0206865CrossRef Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K et al (2018) Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS One 13:e0206865CrossRef
19.
Zurück zum Zitat Sethi S (2021) New “antigens” in membranous nephropathy. J Am Soc Nephrol 32:268–278CrossRef Sethi S (2021) New “antigens” in membranous nephropathy. J Am Soc Nephrol 32:268–278CrossRef
20.
Zurück zum Zitat Duncan G, McCormick C, Tufaro F (2001) The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest 108:511–516CrossRef Duncan G, McCormick C, Tufaro F (2001) The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest 108:511–516CrossRef
21.
Zurück zum Zitat McCormick C, Duncan G, Goutsos KT, Tufaro F (2000) The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci U S A 97:668–673CrossRef McCormick C, Duncan G, Goutsos KT, Tufaro F (2000) The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci U S A 97:668–673CrossRef
22.
Zurück zum Zitat Busse M, Kusche-Gullberg M (2003) In vitro polymerization of heparan sulfate backbone by the EXT proteins. J Biol Chem 278:41333–41337CrossRef Busse M, Kusche-Gullberg M (2003) In vitro polymerization of heparan sulfate backbone by the EXT proteins. J Biol Chem 278:41333–41337CrossRef
23.
Zurück zum Zitat Paulson JC, Colley KJ (1989) Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 264:17615–17618CrossRef Paulson JC, Colley KJ (1989) Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 264:17615–17618CrossRef
24.
Zurück zum Zitat Busse M, Feta A, Presto J, Wilén M, Grønning M, Kjellén L, Kusche-Gullberg M (2007) Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J Biol Chem 282:32802–32810CrossRef Busse M, Feta A, Presto J, Wilén M, Grønning M, Kjellén L, Kusche-Gullberg M (2007) Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J Biol Chem 282:32802–32810CrossRef
25.
Zurück zum Zitat Miner JH (2008) Glomerular filtration: the charge debate charges ahead. Kidney Int 74:259–261CrossRef Miner JH (2008) Glomerular filtration: the charge debate charges ahead. Kidney Int 74:259–261CrossRef
26.
Zurück zum Zitat Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y, Holzman LB, van Kuppevelt TH, Jenniskens GJ, Wijnhoven TJ et al (2008) Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 74:289–299CrossRef Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y, Holzman LB, van Kuppevelt TH, Jenniskens GJ, Wijnhoven TJ et al (2008) Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 74:289–299CrossRef
27.
Zurück zum Zitat Ravindran A, Casal Moura M, Fervenza FC, Nasr SH, Alexander MP, Fidler ME, Herrera Hernandez LP et al (2021) In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol 32:695–706CrossRef Ravindran A, Casal Moura M, Fervenza FC, Nasr SH, Alexander MP, Fidler ME, Herrera Hernandez LP et al (2021) In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol 32:695–706CrossRef
28.
Zurück zum Zitat Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825–835CrossRef Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825–835CrossRef
29.
Zurück zum Zitat Maningding E, Dall’Era M, Trupin L, Murphy LB, Yazdany J (2020) Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California Lupus Surveillance Project. Arthritis Care Res (Hoboken) 72:622–629CrossRef Maningding E, Dall’Era M, Trupin L, Murphy LB, Yazdany J (2020) Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California Lupus Surveillance Project. Arthritis Care Res (Hoboken) 72:622–629CrossRef
30.
Zurück zum Zitat Hanrotel-Saliou C, Segalen I, Le Meur Y, Youinou P, Renaudineau Y (2011) Glomerular antibodies in lupus nephritis. Clin Rev Allergy Immunol 40:151–158CrossRef Hanrotel-Saliou C, Segalen I, Le Meur Y, Youinou P, Renaudineau Y (2011) Glomerular antibodies in lupus nephritis. Clin Rev Allergy Immunol 40:151–158CrossRef
31.
Zurück zum Zitat Ronco P, Plaisier E, Debiec H (2021) Advances in membranous nephropathy. J Clin Med 10:607CrossRef Ronco P, Plaisier E, Debiec H (2021) Advances in membranous nephropathy. J Clin Med 10:607CrossRef
Metadaten
Titel
Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis
verfasst von
Yukihiro Wada
Masayuki Iyoda
Taihei Suzuki
Shohei Tachibana
Nobuhiro Kanazawa
Kei Matsumoto
Hirokazu Honda
Publikationsdatum
24.07.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2021
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-021-03164-9

Weitere Artikel der Ausgabe 5/2021

Virchows Archiv 5/2021 Zur Ausgabe

Neu im Fachgebiet Pathologie